1-20 of 255
M Smith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

S2207: Randomized Phase II Study of the Addition of Targeted Agents to Tafasitamab-Lenalidomide in Transplant Ineligible Patients with Relapsed/Refractory LBCL

Jennifer E. Amengual, Hongli Li, Patrick M. Reagan, Tareq Al Baghdadi, Hayder Saeed, Joseph M Unger, Alexey Danilov, Michael Leblanc, Jonathan W. Friedberg, Sonali M. Smith
Journal: Blood
Blood (2024) 144 (Supplement 1): 3123.2.
https://doi.org/10.1182/blood-2024-199784
Published: 2024
Journal Articles

Comparative in-Vitro Efficacy of CD20xCD3 IgG Bispecific Biosimilar Constructs Against Diffuse Large B Cell Lymphoma (DLBCL) Cell Lines with Different Levels of Expression of CD20

Joshua S. Bray, Gethin R. Thomas, Victoria M. Smith, Sandrine Jayne, Martin J.S. Dyer, Harriet S. Walter
Journal: Blood
Blood (2024) 144 (Supplement 1): 5826.
https://doi.org/10.1182/blood-2024-203884
Published: 2024
Journal Articles

Relationship between Coagulation Factor Levels and Bleeding Post-Cardiopulmonary Bypass

Sheldon Goldstein, Mark M. Smith, Beth Montonye, Brenda Anderson, Michael Kagan, Gregory A. Nuttall
Journal: Blood
Blood (2024) 144 (Supplement 1): 5609.
https://doi.org/10.1182/blood-2024-206196
Published: 2024
Journal Articles

A Randomized Phase 2 Study Incorporating Nivolumab and Brentuximab Vedotin into Radiation-Free Treatment of Early Stage Classic Hodgkin Lymphoma

Ann S. LaCasce, Deepa Jagadeesh, Hun Ju Lee, Lu Chen, David A. Bond, Matthew Weinstock, Matthew Mei, Tatyana Feldman, Allison M. Winter, Jeffrey A. Barnes, Amitkumar N. Mehta, Gaurav Goyal, Sairah Ahmed, Lisa Giulino Roth, Azra Borogovac, Kristie A. Blum, Jane N Winter, Mehdi Hamadani, Sonali M. Smith, Philippe Armand, Ian W. Flinn, Jeremy S. Abramson, Alex F. Herrera
Journal: Blood
Blood (2024) 144 (Supplement 1): 459.
https://doi.org/10.1182/blood-2024-204113
Published: 2024
Journal Articles

Real World First-Line Treatment Strategies and Outcomes in TP53 Mutated and Unmutated Mantle Cell Lymphoma

Jie Wang, Jihao Zhou, Yucai Wang, Javier L. Munoz, Kevin G. Shim, Muhamad Alhaj Moustafa, Firas Baidoun, Kaitlin Annunzio, Narendranath Epperla, Michael McLane, Yasmin H. Karimi, Binh Luu, Stephen E Spurgeon, Cheryl Chang, Zihan Wan, Diamone Gathers, Emily R. King, Marcus P. Watkins, Nancy L. Bartlett, Christine E. Ryan, Genevieve M Gerhard, Philippe Armand, Ann S. LaCasce, Vedha Vaddaraju, Danielle S Wallace, Vaishalee P Kenkre, Chase Junge, Natalie Grover, Jorge A Florindez, Reem Karmali, Alexander V. Stanisic, Chen Zhang, Parameswaran Venugopal, Grace Ying, Caitlin Gribbin, Jia Ruan, Navika D Shukla, Sonali M. Smith, Viktoriya Zelikson, Michael E. Williams, Stefan K. Barta, Omar Elghawy, Jake Schade, Rohini Navalekar, Matthew Matasar, Andrew M Evens, Alexey V. Danilov, Timothy S. Fenske
Journal: Blood
Blood (2024) 144 (Supplement 1): 4406.
https://doi.org/10.1182/blood-2024-194601
Published: 2024
Journal Articles

Minimal Residual Disease (MRD) Status Predicts Outcomes in Patients with Follicular Lymphoma (FL) Treated with Chemo-Immunotherapy on SWOG S0016

Alexey Danilov, Hongli Li, Mazyar Shadman, Lisa M. Rimsza, Ahmad Zebari, Sonali M. Smith, Michael Leblanc, Jonathan W. Friedberg, Christopher Carlson, Joo Y Song
Journal: Blood
Blood (2023) 142 (Supplement 1): 4359.
https://doi.org/10.1182/blood-2023-179612
Published: 2023
Journal Articles

A CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition

Alan Cooper, Sravya Tumuluru, Kyle Kissick, Girish Venkataraman, Joo Y Song, Andrew Lytle, Gerben Duns, Jovian Yu, Nikita Kotlov, Alexander Bagaev, Brendan Paul Hodkinson, Srimathi Srinivasan, Sonali M. Smith, David W. Scott, Christian Steidl, James Godfrey, Justin Kline
Journal: Blood
Blood (2023) 142 (Supplement 1): 851.
https://doi.org/10.1182/blood-2023-182390
Published: 2023
Journal Articles

Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826

Sharon M. Castellino, Hongli Li, Alex F. Herrera, Angela Punnett, Michael Leblanc, Susan K Parsons, David Hodgson, Frank Keller, Richard A. Drachtman, Adam Lamble, Christopher J. Forlenza, Andrew Doan, Sarah C. Rutherford, Andrew M Evens, Richard F. Little, Malcolm A. Smith, Joo Y Song, Sonali M. Smith, Jonathan W. Friedberg, Kara M. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 610.
https://doi.org/10.1182/blood-2023-180107
Published: 2023
Journal Articles

Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826

Sarah C. Rutherford, Hongli Li, Alex F. Herrera, Michael Leblanc, Sairah Ahmed, Kelly L. Davison, Carla Casulo, Nancy L. Bartlett, Joseph M Tuscano, Brian Hess, Pallawi Torka, Pankaj Kumar, Ryan W Jacobs, Joo Y Song, Sharon M. Castellino, Brad S. Kahl, John P. Leonard, Sonali M. Smith, Jonathan W. Friedberg, Andrew M Evens
Journal: Blood
Blood (2023) 142 (Supplement 1): 181.
https://doi.org/10.1182/blood-2023-180114
Published: 2023
Journal Articles

CNS Relapse in T-Cell Lymphoma Index: A Risk Score to Predict Central Nervous System Relapse in Patients with T-Cell Lymphomas

Rahul S. Bhansali, Fredrik Ellin, Miao Cao, Thomas Relander, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R Hwang, N. Nora Bennani, Julio C. Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine Zain, Miguel Ruiz, Jonathan E Brammer, Rishab Prakash, Swami P. Iyer, Adam J. Olszewski, Ajay Major, Sonali M. Smith, Peter A. Riedell, Caroline Goldin, Bradley M. Haverkos, Bei Hu, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M Goodman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita Dwivedy Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Journal: Blood
Blood (2022) 140 (Supplement 1): 1481–1484.
https://doi.org/10.1182/blood-2022-160090
Published: 2022
Journal Articles

Ruxolitinib for Treatment of Steroid Refractory Sclerotic Chronic Graft-Versus-Host Disease (cGVHD): Results of a Multicenter Phase II Trial

Vijaya Raj Bhatt, Valerie K Shostrom, Ayman Saad, Betty K. Hamilton, Krishna Gundabolu, Lori Maness, Virender Kumar, Ram I Mahato, Lynette M. Smith, Taiga Nishihori, Stephanie J. Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 1379–1380.
https://doi.org/10.1182/blood-2022-156340
Published: 2022
Journal Articles

Prospective Multi-Center Phase I/II Trial of Lenalidomide and Dose-Adjusted EPOCH-R in MYC-Associated B-Cell Lymphomas

Kirk Cahill, James Godfrey, Chadi Nabhan, Theodore G. Karrison, Jessica Robertson, Justin Kline, Kenneth S. Cohen, Michael R. Bishop, Walter M. Stadler, Reem Karmali, Parameswaran Venugopal, Seo-Hyun Kim, Aaron P. Rapoport, Sonali M. Smith
Journal: Blood
Blood (2022) 140 (Supplement 1): 6594–6595.
https://doi.org/10.1182/blood-2022-168444
Published: 2022
Journal Articles

Magrolimab in Combination with Rituximab + Chemotherapy in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Joseph Maakaron, Adam S. Asch, Leslie L. Popplewell, Graham P. Collins, Ian W. Flinn, Nilanjan Ghosh, Colin Keane, Matthew Ku, Amitkumar Mehta, Mark Roschewski, Carol O'Hear, Xuehan Ren, Bertha Villa, Indu Lal, Sonali M. Smith, Ranjana H. Advani
Journal: Blood
Blood (2022) 140 (Supplement 1): 3728–3730.
https://doi.org/10.1182/blood-2022-167772
Published: 2022
Journal Articles

Acalabrutinib Plus Rituximab with or without Lenalidomide in Patients with Follicular Lymphoma: A Multipart, Open-Label, Phase 1b Trial

Paolo Strati, Beth Christian, Peter Martin, Becky Champion, Morton Coleman, Richy Agajanian, Sonali M. Smith, Parameswaran Venugopal, Izidore S. Lossos, Robert Kridel, Roser Calvo, Kara Higgins, Deborah M. Stephens
Journal: Blood
Blood (2022) 140 (Supplement 1): 3606–3608.
https://doi.org/10.1182/blood-2022-159158
Published: 2022
Journal Articles

Predictors of Adverse Clinical Outcome in Diffuse Large B-Cell Lymphoma Richter Transformation of CLL/SLL: A Consortium of Richter Transformation Investigators (CORTI) Multicenter Study across 8 US, UK, and Australian Academic Centers

Emily Symes, Zhihong Hu, Stephen K. Walker, Vishakha Sovani, Nicolas Lopez-Hisijos, Barina Aqil, Mir Alikhan, Claudiu V. Cotta, Sean Harrop, Angela Lager, Beenu Thakral, Peter A. Riedell, Carrie Fitzpatrick, Michael J. Thirman, Anand Ashwin Patel, Caner Saygin, Sandra L. Ondrejka, Michael R. Bishop, Amir Behdad, Sandeep Gurbuxani, Daniel A. Arber, M. James You, Richard A. Larson, Sonali M. Smith, Yan Amber Hodgson, Justin Kline, Matthew Ku, Girish Venkataraman
Journal: Blood
Blood (2022) 140 (Supplement 1): 2053–2055.
https://doi.org/10.1182/blood-2022-155950
Published: 2022
Journal Articles

Standard Cytogenetic Risk Stratification Is Not Predictive of CD19 CAR Outcomes and Impact of Disease Burden Varies between Cytogenetic Risk Groups

John C. Molina, Vasant Chinnabhandar, Vanessa A Fabrizio, Michael Kunicki, Holly Pacenta, Jenna Rossoff, Heather E Stefanski, Julie Talano, Amy Moskop, Michael R Verneris, Gary Douglas Myers, Nicole Karras, Christina Baggott, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Susanne H.C. Baumeister, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz, Stephanie M. Smith
Journal: Blood
Blood (2022) 140 (Supplement 1): 10386–10388.
https://doi.org/10.1182/blood-2022-165951
Published: 2022
Journal Articles

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elias Campo, Elaine S. Jaffe, James R. Cook, Leticia Quintanilla-Martinez, Steven H. Swerdlow, Kenneth C. Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Dogan, Andrew L. Feldman, Falko Fend, Jonathan W. Friedberg, Philippe Gaulard, Paolo Ghia, Steven M. Horwitz, Rebecca L. King, Gilles Salles, Jesus San-Miguel, John F. Seymour, Steven P. Treon, Julie M. Vose, Emanuele Zucca, Ranjana Advani, Stephen Ansell, Wing-Yan Au, Carlos Barrionuevo, Leif Bergsagel, Wing C. Chan, Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando Lopez-Guillermo, Maria Victoria Mateos, Elizabeth Macintyre, Ari M. Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano A. Pileri, Miguel Piris, Barbara Pro, Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier-Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz
Journal: Blood
Blood (2022) 140 (11): 1229–1253.
https://doi.org/10.1182/blood.2022015851
Published: 2022
Includes: Supplemental data
Journal Articles

Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL

Clinical Trials & Observations
Peter Martin, Nancy L. Bartlett, Julio C. Chavez, John L. Reagan, Sonali M. Smith, Ann S. LaCasce, Jeffrey Jones, James Drew, Chengqing Wu, Erin Mulvey, Maria V. Revuelta, Leandro Cerchietti, John P. Leonard
Journal: Blood
Blood (2022) 139 (8): 1147–1159.
https://doi.org/10.1182/blood.2021011679
Published: 2022
Includes: Supplemental data
Journal Articles

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Clinical Trials & Observations
Victor Manuel Orellana-Noia, Daniel R. Reed, Ashley Alesia McCook, Jeremy Michael Sen, Christian M. Barlow, Mary-Kate Malecek, Marcus Watkins, Brad S. Kahl, Michael A. Spinner, Ranjana Advani, Timothy J. Voorhees, Anson Snow, Natalie Sophia Grover, Amy Ayers, Jason Romancik, Yuxin Liu, Scott F. Huntington, Julio C. Chavez, Hayder Saeed, Aleksandr Lazaryan, Vikram Raghunathan, Stephen E. Spurgeon, Thomas A. Ollila, Christopher Del Prete, Adam Olszewski, Emily C. Ayers, Daniel J. Landsburg, Benjamin Echalier, Jun Lee, Manali Kamdar, Paolo F. Caimi, Timothy Fu, Jieqi Liu, Kevin A. David, Hanan Alharthy, Jennie Law, Reem Karmali, Harsh Shah, Deborah M. Stephens, Ajay Major, Alexandra E. Rojek, Sonali M. Smith, Amulya Yellala, Avyakta Kallam, Shazi Nakhoda, Nadia Khan, Mohammad Ahsan Sohail, Brian T. Hill, Odeth Barrett-Campbell, Frederick Lansigan, Jeffrey Switchenko, Jonathon Cohen, Craig A. Portell
Journal: Blood
Blood (2022) 139 (3): 413–423.
https://doi.org/10.1182/blood.2021012888
Published: 2022
Includes: Supplemental data
Journal Articles

DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults

Clinical Trials & Observations
Margaret A. Ferris, Amanda M. Smith, Sharon E. Heath, Eric J. Duncavage, Matthew Oberley, David Freyer, Robert Wynn, Sofia Douzgou, John M. Maris, Anne F. Reilly, Melinda D. Wu, Florence Choo, Roel B. Fiets, Saskia Koene, David H. Spencer, Christopher A. Miller, Marwan Shinawi, Timothy J. Ley
Journal: Blood
Blood (2022) 139 (3): 461–464.
https://doi.org/10.1182/blood.2021014052
Published: 2022
Includes: Supplemental data